insights+Analyses Published

We're attuned to (often ahead of) the key issues facing the market. It's about arming investors, consumers, and businesses with the information they need to make sound decisions.
Articles filtered by:
Million
INSIGHTS & ANALYSES

415 Million Reasons Why It’s Time to Hug a Whistleblower

For its fifth year anniversary, we examine the significant rise of the U.S. SEC whistleblower program and its impact on recent rulings for ...

Friday, July 22, 2016

by Jordan A. Thomas
published
INSIGHTS & ANALYSES

A Turning of the Tide: Victim Redress Through Private Antitrust Litigation

We address the differences between the U.S. and EU regimes and how the EU is implementing a new litigation landscape. INTRODUCTION Access to the ...

Monday, July 18, 2016

by Karin E. Garvey
NAPPA-Whitepaper-resized
INSIGHTS & ANALYSES

Post-Morrison: The Global Journey Toward Asset Recovery

This paper provides the current state of some court interpretations of Morrison; practical considerations for institutional investors considering ...

Thursday, June 30, 2016

by Michael W. Stocker, Rachel A. Avan, Michael Korn, and members of the National Association of Public Pension Plan Attorneys (NAPPA) Working Group Morrison Sub-Committee
CREATEsActArticle_AsciollaPerez
INSIGHTS & ANALYSES

Creating a Partial Solution to Delayed Generic Competition

This article explores the benefits and limitations of the proposed legislation, the CREATES Act of 2016. A bipartisan group of U.S. senators recently ...

Friday, June 24, 2016

by Gregory Asciolla, Matthew Perez
chronicle_1
INSIGHTS & ANALYSES

Cash or No Cash – That is No Longer the Question!

Analyzing the Impact of FTC vs. Actavis: We address whether non-cash payments can be unlawful reverse payments under Actavis Introduction The U.S. ...

Friday, April 22, 2016

by Robin A. van der Meulen, Rudi Julius
MAIN-stacked-pills
INSIGHTS & ANALYSES

“Shall We Dance?”— Biologic-Biosimilar Competition Under the Biologics Price Competition and Innovation Act

As more biosimilar applications are filed, courts will inevitably face the novel and complex issues posed by the BPCIA with increasing frequency. I. ...

Monday, December 14, 2015

by Gregory Asciolla, Matthew Perez
« 1 ...
3 4 5 6 7